enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Amgen (AMGN) to Add Stomach Cancer Drug With Five Prime ... - AOL

   www.aol.com/news/amgen-amgn-add-stomach-cancer...

   Amgen (AMGN) inks a $1.9-billion deal to acquire clinical-stage biotech, Five Prime Therapeutics, to boost its oncology pipeline. Amgen (AMGN) to Add Stomach Cancer Drug With Five Prime Buyout ...

3. Amgen Inks $1.9B Deal To Buy Five Prime Therapeutics ... - AOL

   www.aol.com/news/amgen-inks-1-9b-deal-091043469.html

   Amgen has agreed to snap up clinical-stage biotech Five Prime Therapeutics for an equity value of $1.9 billion, to strengthen the company’s oncology candidates. Five Prime shares surged 78.7% to ...

4. Why Five Prime's Stock Is Trading Higher Today - AOL

   www.aol.com/news/why-five-primes-stock-trading...

   It has the following product in pipeline: Cabiralizumab, FPA150, Bemarituzumab and Immuno-Oncology.Five Prime Therapeutics shares were trading up 20.53% at $5.30 on Monday. The stock has a 52-week ...

5. Is Five Prime Therapeutics Inc (FPRX) Going to Burn These ...

   www.aol.com/news/five-prime-therapeutics-inc...

   For premium support please call: 800-290-4726 more ways to reach us

6. Is Five Prime Stock a Buy Right Now? This Is What You ... - AOL

   www.aol.com/news/five-prime-stock-buy-now...

   Change is in the air. A new President-elect and the possibility of an end to the pandemic. Some things, however, will always stay the same.Like small cap biotech stocks skyrocketing following the ...

7. Five Prime Therapeutics (FPRX) Expected to Beat Earnings ...

   www.aol.com/news/five-prime-therapeutics-fprx...

   Five Prime Therapeutics (FPRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

8. Recap: Five Prime Therapeutics Q3 Earnings - AOL

   www.aol.com/news/recap-five-prime-therapeutics-q...

   Shares of Five Prime Therapeutics (NASDAQ:FPRX) were unchanged in after-market trading after the company reported Q3 results.Quarterly Results Earnings per share increased 28.16% over the past ...

9. Estimating The Fair Value Of Five Prime Therapeutics, Inc ...

   www.aol.com/news/estimating-fair-value-five...

   For premium support please call: 800-290-4726 more ways to reach us